🔵 #ESTRO25 Press release
PORTEC-4a: Phase III trial shows molecular profiling can safely reduce radiation for women with endometrial cancer and optimise treatment for patients at a higher risk.
👉 https://t.co/EHhjE8mZug
#endometrialcancer#radiotherapy
Prophylactic IV magnesium administration was associated with a lower risk of cisplatin-associated acute kidney injury (CP-AKI) in patients with cancer undergoing cisplatin chemotherapy. https://t.co/64fsal40gm
Special Session III: Building a #Brachytherapy Practice unveils the secrets of cultivating a thriving #brachy practice. Join key thought leaders as they take center stage at #WCB2024 and share their insights & strategies. https://t.co/h2K2XjR7tE @AndrewFarach@ANViswanathanMD
Wondering about the management of locally advanced cervical #cancer?
Do not miss the ENYGO #tumor board #webinar.
📅 Jun 27, 2024 06:00 PM CET
Register here: https://t.co/lxUdKjuIUf
New article alert (Vol 195)
Reirradiation for recurrent gynecologic cancer using high-dose-rate brachytherapy in Japan: A multicenter survey on practice patterns and outcomes
Fumiaki Isohashi et al.
https://t.co/k4zf3eSEKy
https://t.co/WAhBd7TP14
Cervical Cancer is Preventable!💪🏼
We have two great tools - HPV vaccination and regular cervical cancer screening - which are both important👌🏼
#CervicalCancerAwareness ✅
In treatment planning for high-dose-rate (HDR) single-channel vaginal cylinder brachytherapy, the dose distribution along the cylinder is invariably influenced by the anisotropy of the source.
https://t.co/nhTP06rZzg
Do you know what the ESGO Prevention Committee is up to? A lot! At its meeting this week, the group discussed ongoing & future projects that aim to help prevent #cervicalcancer—like our upcoming webinar on CIN Management!
👉 https://t.co/OgWsPbOoJI
#gynonc#oncoalert